ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,171, issued on Sept. 9, was assigned to University of Kentucky Research Foundation (Lexington, Ky.), Memorial Sloan-Kettering Cancer Center (New York) and St. Jude Children's Research Hospital Inc. (Memphis, Tenn.).

"Pharmaceutically active pyrazolo-pyridone modulators of DCN1/2-mediated cullin neddylation" was invented by Hoshin Kim (Lexington, Ky.), Rodney Kiplin Guy (Lexington, Ky.), Jared T. Hammill (Lexington, Ky.), Daniel Charles Scott (Marion, Ky.), Brenda Arlene Schulman (Martinsried, Germany) and Bhuvanesh Singh (Old Westbury, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A DCN1/2-mediated cullin neddylation modulator; a method for t...